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summary
Recrudescing Plasmodium falciparum parasitaemia is attributed to the switching of PfEMP1, a variant antigen family
encoded by the var gene repertoire, and the host’s immune response. We have developed a mathematical model which
incorporates var gene switching, and variant specific, non-variant specific and non-specific immunity. By conducting a
sensitivity analysis of the model we have defined the parameter limits which produce chronic and recrudescing infections.
We explore 3 switching mechanisms: ordered, random and uncoupled switching. We show that if var genes switch on and
off independently at variable rates through the repertoire a chronic clinical infection is predicted. The fastest switching-
on rate that produces a chronic infection is 0–03% per generation. The model predicts that non-variant specific immunity
plays an important role in reducing disease severity. This work illustrates the complex relationship between the malaria
parasite and its host and shows that var gene switching at rates substantially slower than 2% are essential for parasite
survival.
Key words: Plasmodium falciparum, var gene, switching rates, switching mechanism, disease severity, mathematical
modelling.
introduction
Parasite recrudescence and fever characterize Plas-
modium falciparum malaria in non-immune humans
(Collins & Jeffery, 1999). The peaks of recrude-
scence, often separated by 3-week intervals (Collins
& Jeffery, 1999), are attributed to the switching of
P. falciparum encoded variant antigens exposed on
the surface of infected erythrocytes (Biggs et al.
1991). Variant surface antigens have also been de-
scribed in other human (P. vivax and P. ovale),
rodent (P. berghei and P. chabaudi) and simian (P.
knowlesi, P. fragile and P. coatneyi) malaria species
(Saul, 1999).
The P. falciparum erythrocyte membrane protein
(PfEMP1) is a diverse set of variant proteins encoded
by var genes (Baruch et al. 1995; Su et al. 1995).
Each haploid malaria genome is thought to contain
approximately 50 var genes (Su et al. 1995), although
there may be fewer. Only 1 full-length var transcript
is shown to be exposed as a PfEMP1 variant on each
* Corresponding author: Malaria Biology Lab, Division
of Infectious Diseases and Immunology, The Queensland
Institute of Medical Research, P.O. Royal Brisbane
Hospital, Qld 4029, Australia. Tel: ›61 7 33620420. Fax:
›61 7 33620104. E-mail : sarahM!qimr.edu.au
 Present address: Malaria Vaccine Development Unit,
NIAID}LPD, National Institutes of Health, Rockville
MD 20852, USA.
erythrocyte surface (Chen et al. 1998; Taylor et al.
2000). The actual copy expressed by a cloned line
can switch and in vivo, successive waves of parasites
in a single host exhibit different surface antigen
serotypes (Saul, 1999). In P. falciparum, expression
of PfEMP1 is associated with the adherence of
infected erythrocytes to endothelial cells and unin-
fected erythrocytes. Not only do different PfEMP1
variants have different serotypes, but the binding
specificity of the infected erythrocytes also depends
on the PfEMP1 type expressed (Biggs et al. 1992;
Gardner et al. 1996). Thus, the expression of
different PfEMP1 types may be associated with
different aspects of severe malarial disease such as
cerebral malaria (Carlson et al. 1990; Rowe et al.
1995), severe non-cerebral malaria (Raventos-Suarez
et al. 1985) and infection of the placenta (Fried &
Duffy, 1996; Beeson et al. 2000).
The mechanism and regulation of PfEMP1 vari-
ant switching is not understood. It has been proposed
that the cyclical expression of a particular surface
antigen, the host’s corresponding immune response
to that antigen and the concurrent switching of the
surface antigen serotype of a minor proportion of the
parasite population is crucial to the establishment of
a stable and chronic malaria infection (Saul, 1999).
The purpose of this paper is to present the results
of a stochastic simulation model which investigates
different mechanisms of switching, and the inter-
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Fig. 1. The interaction of parameters which affect
parasite load and disease. The parasite load (i.e. total
number of parasites in the host) stimulates variant
specific (VSI) and non-specific immunity (NSI). VSI is
triggered once the antigenic threshold is exceeded and a
time-lag occurs before anti-PfEMP1 antibodies become
effective. The switching of var genes, which encode
PfEMP1 variants, is determined by the mechanism and
rate and influences the antibody response and thus the
parasite load. NSI takes effect in the cycle that the
threshold is exceeded. The magnitude of NSI is an
indicator of the fever response and determines the
degree to which the parasite load decreases. It is also
associated with the clinical presentation of disease.
Clone-specific immunity, against conserved
determinants of a clonal population, is modelled by a
decrease in the parasite growth rate, m, and is not
influenced by the parasite load.
action between var gene switching and human
immune responses. Intra-host models of malaria
infection are not new (reviewed by Molineaux &
Dietz, 1999), but many are deterministic even
though malaria infection is a stochastic process
dominated by probabilistic events. Recently, Molin-
eaux et al. (2001) reported a discrete-time simula-
tion model incorporating a constant switching rate of
2% per generation, a switching probability that is
modulated by the presence of variant specific
antibodies and highly variable base line growth rates
for each variant. The aim of their work was to
accurately fit the model to a limited set of malaria-
therapy cases. In contrast, the relatively simple
stochastic simulation mathematical model reported
here is a generalized model which is not patient
specific. We used our model in a sensitivity analysis
to investigate the relationship between the PfEMP1
switching rate and parameters involved with the
human immune response for several possible switch-
ing mechanisms. The model incorporates a rapidly
acting, density-dependent, non-specific immunity, a
specific immunity to individual PfEMP1 variants,
and a non-variant, specific immunity. The role of
each of these types of immunity in the development
of a chronic infection is also explored.
method
The mathematical model is a stochastic model which
describes var gene switching and the host’s immune
response to specific malaria antigens. Fig. 1 illu-
strates the interaction between the parameters of the
model. The basic model incorporates non-specific
immunity (NSI), PfEMP1 variant specific immunity
(VSI) and non-variant specific immunity, referred to
as ‘clone specific immunity’ (CSI). CSI may be
against polymorphic antigens (such as the vaccine
candidates merozoite surface protein-1 and apical
membrane antigen-1) resulting in a different impact
on different parasite clones, or CSI may be against
common antigens resulting in pan-specific immun-
ity. This distinction will be important when the
model is extended to multiple infections. However,
only clonal infections are considered here.
For simplicity we assume that each sporozoite
which infects a naı$ve human host produces 40000
genetically identical merozoites, all expressing the
same var gene. These merozoites are released into
the blood-stream 6 days after infection (Coatney et
al. 1971). During the erythrocytic cycle, on average
16 merozoites are released per schizont every 48 h
(Coatney et al. 1971). Only a proportion of these
merozoites invade new RBCs and survive to ma-
turity; the other proportion are killed by clone-
specific immunity (CSI). CSI is implemented as a
reduction in the parasite growth rate from 12-fold
per cycle, the growth rate measured in P. falciparum-
infected malaria naı$ve people (Cheng et al. 1997). In
the model the effect of CSI remains constant
throughout the infection. However, in vivo, the level
of CSI may increase as the infection progresses.
Once the erythrocytic cycle begins, the parasites
may switch variant antigens which are encoded by
the var genes (Baruch et al. 1995). We assume each
parasite has a repertoire of 50 var genes (Su et al.
1995). Three different var gene switching mech-
anisms are investigated and are based on exper-
imental observations of clonal antigenic variation in
malaria parasites. The first switching mechanism
modelled is sequential and regulated: a single var
gene can only switch to the next var gene in the
series. The probability of switching from var i to var
j is zero, except when jfl i›1 in which case the
probability is 1 (Table 1). The switching rates for
each var gene in the repertoire can be either equal,
randomly selected within a specified range or linearly
decreasing. This ordered mechanism mimics the
sequential appearance of P. fragile variant antigens,
where each variant corresponds to a new wave of
parasitaemia (Handunnetti, Mendis & David, 1987).
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Table 1. The probability of switching from one var gene to the next var gene according to the switching
mechanisms
(The switching mechanisms modelled were ordered, random and uncoupled. Variations of the mechanisms incorporated
a switching bias (sbias) which created a series of non-uniform probabilities and resulted in the expression of fast (major)
and slow (minor) switching var genes.)
Switching mechanism Probability, p, of switching from var i to var j (p[i, j])
1. Ordered p[i, j]fl1, if jfl i›1
p[i, j]fl0, if j1 i›1
2. (a) Random-uniform p[i, j]fl1}49
(b) Randon-non-uniform p[1, 1]fl1
p[1, j]flp[1, jfi1]}sbias for jfl2 … 50,
zfl 3&!
j="
p[1, j],
(i) next type p[i, j]flp[1, j]}z
(ii) next and last p[i, j]flp[1, 51fij]}z for jfl1 … ifi1 and,
p[i, j]flp[1, jfii›1]}z for jfl i … 50
3. Uncoupled p[1]fl1
p[i]flp[ifi1]}sbias
z fl 3&!
i="
p[i]
(i) switching on p
on
[i]flp[i]}z
(ii) switching off p
off
[i]flp[i]}z
Table 2. The range of parameter values simulated which control the parasite population growth
(The upper and lower limits for each variable were determined by conducting 2000 simulations through the range of
values presented, while the values of the other variables were kept constant.)
Description Variable Range tested
Proportion of parasites
killed by CSI
m (eq. 1) 0–25, 0–5, 0–75
Parasite load of a
specific var type
required to trigger the
specific anti-PfEMP1
antibody
AbTL 0–2, 2, 20, 200, 2000 (pRBC}ll)
Time-lag between
AbTL and when anti-
PfEMP1 antibodies
become effective
D 5, 7, 9, 11 (Days)
Parasite load required
to trigger NSI
T (eq. 2) 20, 200, 2000, 20000 (pRBC}ll)
Feedback constant of NSI k (eq. 2) 0–5, 0–25, 0–125, 0–0625, 0–03125, 0–016, 0–008, 0–004, 0–002, 0–001
Var gene switching rate
of parasites per
generation (48 h cycle)
10−#, 10−$, 10−%, 10−&, 10−’, 10−(, 10−), 10−*, 10−"!, 10−"", 10−"#
Switching bias for var
gene selection when
using non-uniform
switching rates
sbias 1, 1–1, 1–2, 1–4
The second mechanism modelled allows a par-
ticular var gene to switch to any other var gene in a
random manner. The basic mechanism ensures that
each var gene has an equal chance of switching on so
that the probability of switching from var i to var j
is 1}49. Two variations of this mechanism in-
corporate a switching bias (sbias) (Table 2) which
creates a repertoire of non-uniform switching proba-
bilities. The first variation ensures that the prob-
ability of switching is dependent on the next var
gene to be expressed (Table 1 – eq. 2b(i)). The
second variation ensures that the probability of
switching is dependent on the current var gene
expressed and the next to one to be switched on
(Table 1 – eq. 2b(ii)). This variation also allows
backward switching to a previously expressed var
gene. These variations of the random mechanism
model the expression of major and minor variant
serotypes in P. chabaudi infections, where several
unique variants were shown to be present sim-
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ultaneously during a wave of parasitaemia (Brannan,
Turner & Phillips, 1994).
The third mechanism, referred to as uncoupled
switching, allows an expressed var gene to switch off
independently of another var gene switching on,
such that var i is switched off independently of var j
switching on (Table 1 – eq. 3). Thus a parasite may
have 0, 1 or 2 var genes expressed at any one time.
The on and off switching rates can be equal or
unequal, and either uniform (sbiasfl1) or non-
uniform (sbias"1) through the var gene repertoire.
This mechanism models the loss and then re-
expression of variant antigens on infected erythro-
cytes (reviewed by Newbold et al. 1999). In the
model, parasites which do not express any var genes
are killed (this simulates the action of the spleen).
Variant specific antibodies develop once the num-
ber of parasites expressing a particular var antigen
reaches a defined antigenic threshold (AbTL). To
incorporate the time required for antibody devel-
opment in the host, a time-lag must be exceeded
before anti-PfEMP1 antibodies take effect. The
number of parasites surviving CSI and variant
specific immunity (VSI) follows a binomial dis-
tribution (eq. 1).
X
i
EBi†X
i
, (1fim)K(X
i
)·, (1)
where X
i
is the number of parasites expressing var i,
m is the probability of a parasite being killed by
clone-specific immunity and K(X
i
) is the probability
of a parasite expressing var i surviving the specific
immunity against var i.
The model assumes that non-specific immunity
(NSI) becomes functional when the total number of
parasites exceeds a defined parasite threshold level
(Collins & Jeffery, 1999; M. Gatton, personal
communication). The degree of parasite killing
invoked by NSI is a function of the difference
between the parasite load and the parasite threshold.
In preliminary modelling a number of functions
were considered with an exponential function con-
sistently giving the most realistic patterns of para-
sitaemia. For simplicity, it is assumed that the
parasite threshold and feedback constant, k, are
constant throughout an infection, although in vivo,
one or both may change during the course of an
infection. Unlike VSI, the effect of NSI is im-
mediate. The number of parasites surviving NSI is
described using a binomial distribution (eq. 2).
X
i
EBi(X, e−k(X−T)/T), (2)
where X is the total parasite load, T is the parasite
threshold that stimulates NSI and k is the feedback
constant (0!k%1). The probability of parasites
surviving NSI is inversely proportional to k. It
follows that an increase in the value of k, decreases
the parasite load through non-specific immune
killing.
The total number of parasites, the number of
parasites expressing each var gene, the day the
variant expressing a particular var gene reaches its
maximal parasitaemia and the maxima and minima
of each parasitaemia peak are tracked and recorded
throughout the simulation period of 200 days. Each
simulation of the model produces a data output and
a graph of parasite recrudescence over time with a
fever indicator proportional to the NSI response. A
sensitivity analysis of 2000 simulations on each
parameter value (Table 2) was conducted to de-
termine parasitaemia patterns comparable with at
least part of the parasite profiles recorded from 148
neurosyphilitic patients treated with P. falciparum
who were not given anti-malarial treatment to
modify or eliminate the primary episode of para-
sitaemia (Collins & Jeffery, unpublished data).
Parameter sets which were able to produce peak
parasite loads between 10$ and 10& parasitized
RBC}ll blood (pRBC}ll), an infection exceeding 50
days, a fever response and recrudescing parasitaemia
with an approximate 3-week interval between peaks
were considered as realistic patterns of malaria
infections. The switching rate reported from the
sensitivity analysis is the rate multiplied by the
highest probability of switching within the reper-
toire.
results
The stochastic nature of the model produces vari-
ation in graphical outputs when the same set of
parameter values are used thus reproducing the
individuality of malaria infections. Fig. 2 compares
a sample of the clinical data (Collins & Jeffery,
unpublished data) with a model output.
Clone-specific immunity
For all mechanisms of switching, chronic patterns of
parasite recrudescence reaching levels between 10$
and 10& pRBC}ll were achieved with CSI resulting
in growth rates of 8-fold per cycle or above (Fig. 3).
When CSI caused the growth rate to fall to 4-fold
per cycle, patent chronic periodic infections could
only be achieved when the threshold required to
trigger VSI was greater than 2 pRBC}ll. However,
the patterns of parasitaemia generated did not
represent the other features of a chronic clinical
infection.
Non-specific immunity
In the model, 2 factors determine the effects of NSI:
the parasitaemia which triggers NSI and the size of
the feedback constant (k). Realistic infection patterns
were obtained when the parasite threshold was
between 200 and 2000 pRBC}ll. Deterministically,
there is a simple relationship between the parasite
growth rate, the parasite threshold (T), the feed back
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Fig. 2. The patterns of parasite recrudescence (top
curve) and fever indicator (spikes) in a Plasmodium
falciparum infection. (A) Clinical case of patient infected
with the El Limon strain of P. falciparum (Collins &
Jeffery, unpublished data). (B) Model output of
uncoupled and non-uniform switching between var
genes: fastest on ratefl10−) and fastest off ratefl10−#
switching parasites per generation. The thresholds for
VSI and NSI are 2 pRBC}ll and 200 pRBC}ll,
respectively, with a low NSI feedback constant (kfl
0–03125). NSI, in terms of the fever response, causes
sharp oscillating peaks within each recrudescence.
Parasite recrudescences begin on Days 20 and 68 and
occur after a genetic bottleneck which results from the
effect of VSI.
constant (0!k!1) and the level at which the
parasitaemia stabilizes (ignoring the effect of VSI).
This relationship is described by:
parasitaemiafl (T}k)ln(growth rate)›T.
For a large feedback (as kU 1) the average para-
sitaemia stabilizes close to, but above, the parasite
threshold, T, but the instantaneous values show
considerable variation. Since NSI is only applied
once per cycle as the schizonts rupture, the feedback
loop is destabilized, and a large feedback constant
causes a big spike of NSI. This is depicted in the
fever response and results in a high proportion of
parasites being killed. The parasite population
requires several cycles to again reach the parasite
threshold, at which time the NSI is triggered and the
process repeats itself. This behaviour resembles the
early stages of a malaria infection with high fever
spikes and a degree of chaotic behaviour in both the
parasite levels and fever response. When the feed-
back is small (kU 0, k10), the parasitaemia stab-
ilizes at a level much greater than the parasite
threshold, resulting in small and consistent NSI
responses per cycle. This resembles the later stages
of a malaria infection. Irrespective of the amount of
feedback, the deterministic analysis indicates that
NSI alone is not enough to control parasitaemia
since the equilibrium is always above the fever
threshold. For any feedback constant value, the size
of the fever response (and presumably the fever
experience in vivo) is closely related to the parasite
growth rate and thus the level of CSI. By increasing
CSI, the growth rate decreases causing a substantial
decrease in the size of the parasite spikes due to NSI
and the size of the fever response (Fig. 3).
Var-specific immunity
Realistic patterns of infection occur when the
antigenic threshold is between 2 and 200 pRBC}ll.
When the threshold is lower (0–2 pRBC}ll) the
infection does not exceed 20 days. There is also no
fever response, since the parasite population is killed
by variant specific antibodies before the fever
threshold is triggered and before any parasites switch
to a new unexpressed var gene. A higher threshold of
2000 pRBC}ll results in the parasitaemia reaching
10’ pRBC}ll. This is equivalent to a 20% para-
sitaemia which would kill the patient since, unlike
the NSI response against the parasite and its toxins,
there is a delay between antibody production and
release in response to variant antigens.
We investigated 5, 7, 9 and 11 day delays of variant
specific antibody killing. Irrespective of the swit-
ching rate and the level of NSI, low parasitaemia
levels and regular recrudescence patterns were
predicted with the 5 day time-lag. This reflected
dominant antibody control. A 9 or 11 day time-lag
resulted in a pattern of parasitaemia consistently
above the detection threshold of 10 pRBC}ll, reflect-
ing weak antibody control. A 7 day time-lag
produced the most realistic recrudescing patterns of
parasitaemia with peaks and troughs above and
below the detection threshold.
Interactions of the immune response
The parasite load is dependent upon the ratio of the
VSI and NSI thresholds. For a chronic and periodic
infection to occur, the VSI antigenic threshold must
be at least 10-fold lower than the NSI parasite
threshold. A ratio less than 10 results in the
parasitaemia being controlled by NSI alone which is
depicted by sharp oscillating peaks. Thus the
parasitaemia never falls below the detection limit
and the classical patterns of recrudescence do not
occur. A maximum difference of 1000-fold is
possible (e.g. VSI threshold is 2 pRBC}ll and NSI
threshold is 2000 pRBC}ll). A ratio greater than this
results in no fever response with the parasitaemia
controlled by VSI before the NSI threshold is
reached. Therefore NSI plays a significant role in
controlling parasite levels during the antibody time-
lag period but alone cannot control the parasitaemia.
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Fig. 3. The decrease in fever response (disease severity) associated with a decrease in the parasite growth rate
(modelled by CSI). Top curve represents the parasitaemia and the spikes represent the fever indicator. For all graphs
the thresholds for VSI and NSI are 2 pRBC}ll and 200 pRBC}ll, respectively, with a medium NSI feedback
constant (kfl0–0625) and a slow switching on rate of 10−) for the sequential and random models and an on rate of
10−’ for the uncoupled model.
Fig. 4. The patterns of parasite recrudescence resulting from fast, medium and slow var gene switching rates. For all
graphs the thresholds for VSI and NSI are 2 pRBC}ll and 200 pRBC}ll, respectively, with a medium NSI feedback
constant (kfl0–0625) and a level of CSI which allows a 12-fold parasite population growth rate.
P. falciparum var gene switching rates 231
Days of infection
p
R
B
C
/l
l
Fig. 5. Patterns of parasite recrudescence (top curve)
produced by non-uniform random switching model. The
spikes represent the fever indicator. Var gene switching
is 10−) switching parasites per generation and is
dependent upon the next var gene to be expressed. The
thresholds for VSI and NSI are 2 pRBC}ll and
200 pRBC}ll respectively, with a medium NSI feedback
constant (kfl0–0625) and a level of CSI resulting in a
12-fold growth rate.
The var gene switching mechanism
Using the parameter limits determined by the
sensitivity analysis, the sequential, random and
uncoupled switching mechanisms were evaluated to
determine which produced the most realistic patterns
of parasitaemia and fever.
The sequential switching of var genes using any of
the rate variations, results in regular patterns of
recrudescence with little chaotic behaviour. When
switching rates decrease through the var gene
repertoire, periodic recrudescences with approxi-
mate 21-day periodicity between peaks occur. These
regular patterns resemble the middle phase of an
infection (Fig. 4, top middle panel).
Random switching of var genes at a uniform rate
can not predict chronic infections (Figs 3 and 4,
middle panels). However, when switching is random
and non-uniform, with some var genes in the
repertoire having a higher probability of switching
relative to the other var genes, the characteristic
patterns of recrudescence can be predicted at slow
switching rates (Fig. 5).
Realistic patterns of recrudescence are predicted
by the uncoupled on and off switching of var genes
at equal (Fig. 3, bottom middle and left panels) and
unequal switching rates (Fig. 2B). Fig. 6 illustrates
the expression of 11 different var genes during the
first 150 days of an infection, showing that with the
uncoupled mechanism only a small subpopulation of
parasites, usually at an undetectable level, will
express 2 var genes simultaneously. The switching
off of one of these genes allows these variants to
recrudesce and maintain the infection.
The var gene switching rate
The switching rate is modelled as the rate multiplied
by the probability of switching and this switching
rate is reported as the fastest switching var gene in
the repertoire. For all switching mechanisms fast
switching rates of 10−# to 10−$ switching parasites per
generation (equivalent to 1% and 0–1%) result in a
non-recrudescing acute parasitaemia of less than 50
days. This fast switching exhausts the var gene
repertoire resulting in short infection periods.
For sequential switching of var genes with decreas-
ing rates through the repertoire, the upper and lower
limits on the fastest rate are 10−( to 10−* switching
parasites per generation respectively. The upper and
lower limits for purely random var gene switching
are lower at 10−* and 10−"# switching parasites per
generation respectively. When a non-uniform ran-
dom switching mechanism is used, the respective
upper and lower limits of the fastest rate increase to
10−’ and 10−"" switching parasites per generation.
The upper and lower parameter limits on the
switching-on rate for the basic uncoupled mech-
anism are 3‹10−& and 3‹10−( switching parasites
per generation. Using the switching bias to create
non-uniformity of the total switching rate through
the repertoire predicts higher upper and lower
parameter limits for the fastest switching-on rates of
var genes of 3‹10−% and 3‹10−’ switching parasites
per generation respectively. For both cases, the
upper and lower parameter limits on the switching-
off rate equals those on the switching-on rate.
When the on and off switching rates are unequal
an interesting balance occurs: a fast on rate predicts
chronic patterns of parasitaemia only when the off
rate is slow. Likewise, a slow on rate couples with a
fast off rate. When the switching through the
repertoire is uniform but the switching-on and -off
rates are unequal, the upper and lower limits on the
switching-on rate are 10−% and 10−* switching
parasites per generation respectively. The upper and
lower limits on the switching-off rate are 10−# and
10−) switching parasites per generation respectively.
A fast on rate of 10−% couples with slow off rates of
10−( and 10−) and a slow on rate of 10−* couples with
fast off rates of 10−# and 10−$ switching parasites per
generation. When the switching through the rep-
ertoire is non-uniform, the upper and lower limits on
the switching-on and -off rates are the same as those
when switching through the repertoire is uniform,
indicating that the fastest possible respective switch-
ing-on and -off rates are 10−% and 10−# switching
parasites per generation.
discussion
Malaria is a complex disease which requires a delicate
balance between parasite growth and host immunity
to enable survival of both the parasite and its host.
The variability and switching of PfEMP1 antigens is
a major factor in the survival of the parasite
population until transmission. The host produces a
strong immune response against PfEMP1 and other
polymorphic antigens, as well as a non-specific
response in an attempt to destroy the parasite
population. Such complexity and interactions are
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Fig. 6. The 4 panels represent a single Plasmodium
falciparum malaria infection modelled by the uncoupled
switching of var genes. The line represents the detection
limit of 10 pRBC}ll. Each panel shows a wave or waves
of parasitaemia consisting of different types of expressed
var genes at different parasite levels during the course of
infection. A wave of parasitaemia may consist of
predominantly 1 expressed var gene product (e.g. the
first parasite peak) or many expressed var gene products
(e.g. the second parasite peakflfirst parasite
recrudescence). The uncoupled on and off switching of
var genes allows a small subpopulation of parasites to
express 2 var gene products. The size of this
subpopulation depends upon the switching-on and -off
rates. These doubly expressed variant parasites are
susceptible to the antibodies against either of the
expressed var genes. For example, in the first peak the
dominant variant expresses var 1 (A) and the minor
variants of interest express vars 1 and 2, 1 and 4, 1 and
5, and 1 and 7 (B) and 1 and 9 (D), where vars 5 and 7
are below 0–01 pRBC}ll in the first peak. Antibodies
against the expressed var 1 gene product cause the
minor populations to follow the same pattern of
parasitaemia as that of the major population. Some
parasites in the minor populations are able to survive
the VSI against the var 1 gene product by switching var
1 off. These parasites are then able to recrudesce
whereas the major population expressing only var 1 falls
below 0–001 pRBC}ll before Day 30 (A). Many minor
populations will remain undetectable until later in the
infection (e.g. var genes 3, 6 and 8 which surpass the
difficult to investigate experimentally but can be
explored with mathematical models. Our model of a
malaria infection investigates the complex patterns
of parasite recrudescence in an initially non-immune
patient and provides limits on the thresholds gover-
ning host immunity and on the range of var gene
switching rates according to specific switching
mechanisms.
The model presented here incorporates the suc-
cessive switching of individual parasite var genes,
the production of variant specific antibodies and a
negative feedback loop of the NSI response which
kill a proportion of all parasites. The mathematical
model described by Molineaux et al. (2001) also
incorporates these features but many are based on
assumptions which make it biologically unlikely.
First, the switching from var i to var j requires
immune modulation, such that the actual probability
of switching to var j is dependent upon the presence
of variant specific antibodies against other expressed
var gene products. Once the new var gene is switched
on, the switching probability between other var
genes increases. Our model incorporates a far more
simplistic and biologically plausible switching meth-
odology where the switching probabilities are in-
herent and are therefore not modulated by the
immune response. P. falciparum variants switch in
vitro where there is no immune pressure, thus
supporting an inherent switching mechanism (Biggs
et al. 1992; Roberts et al. 1992). In vivo, the
expressed var gene products are undoubtedly modu-
lated by the host’s immune response resulting in
selection pressure against the PfEMP1 variant
antigens and thus against the specific variant parasite
subpopulations (Bull et al. 1998; Iqbal et al. 1997;
Saul, 1999).
Second, Molineaux et al. (2001) fitted the model to
allow each PfEMP1 variant to have different growth
rates. However, their model described a monoclonal
infection in which all parasites are genetically
identical other than the expressed var gene. The
authors justified the use of different variant growth
rates from their estimation of a broad range of initial
growth rates in the acute phase of parasitaemia.
However, there are many reasons why these initial
growth rates vary, without invoking different growth
rates due to different var gene expression. For
example, this range of growth rates comes from
single observations in different people who were
infected with 1 of 3 different parasite lines. Even
when the same line was used, the inocula of these
lines was associated with different passage histories.
There is also a substantial error in measuring initial
detectable threshold in peak 3, var 9 in peak 4 and var
11 in peak 5), and others always remain at very low
undetectable levels throughout the whole infection (e.g.
var gene 10 shown in D).
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growth rates when the parasitaemia is low, and, in
the method used by Molineaux et al. (2001) at least
part of that parasite growth occurred during a non-
exponential growth period which was probably due
to the effect of non-specific immunity. Although
Molineaux et al. (2001) argued that the survival of
the schizont may depend upon the var gene expres-
sed and the subsequent adherence properties of the
PfEMP1 antigen, we can find no direct evidence to
show that at the very low initial parasitaemia
cytoadherence is limiting. There is, however, direct
evidence that the same parasite inoculum produces
initial growth rates which vary from person to
person (Lawrence et al. 2000), albeit at a con-
siderably lower variation than that required by the
Molineaux model. As we show in this paper, such
assumptions are not required to generate an adequate
model of malaria.
In contrast to the Molineaux model, the model
presented here uses simple equations that require
few input parameters to describe the various immune
responses. Furthermore the model is generalized in
that no individual specific data are required, making
the model applicable to many situations. This
relative simplicity does not appear to compromise
the reality of the model output since it is able to
explain the many features of a malaria infection. We
have shown that var genes switching on indepen-
dently of other var genes switching off produces
realistic patterns of parasite recrudescence. Com-
pared to the sequential and random mechanisms,
uncoupled switching may be the most biologically
plausible mechanism for the control of gene ex-
pression. Supporting evidence for the uncoupled
mechanism comes from several experimental obser-
vations of new variants arising in animal models : the
expression of ‘variant-negative’ Plasmodium infected
RBCs from a cloned population, which later become
‘variant-positive’ (reviewed by Newbold et al.
1999); the ordered expression of variants in suc-
cessive waves of parasitaemia (Handunnetti et al.
1987); and the expression of major and minor
variants and the detection of several unique variants
present simultaneously during a wave of parasita-
emia (Brannan et al. 1994). The uncoupled mech-
anism allows either 0, 1 or 2 var gene products to be
expressed on the surface of an infected RBC, a
unique concept for var gene expression. The ma-
jority of parasites will express a single var gene.
However, a small proportion of the population may
not express any var genes. In vivo, these parasites are
more likely to be removed from the circulation by
the spleen (Saul, 1999). Another small proportion
may express 2 different var genes, eliciting a stronger
anti-PfEMP1 response and thus helping to regulate
parasite growth. At first it appears that the uncoupled
mechanism contradicts the experimental evidence
that only 1 var gene product is expressed (Chen et al.
1998; Taylor et al. 2000). However, only a very small
proportion of the parasites express 2 var genes
(’1%) and it would not be expected that this
subpopulation would be detected in bulk cultures
(Taylor et al. 2000), and highly unlikely that a
doubly expressing parasite would be selected for
single cell micro-manipulation (Chen et al. 1998).
The experimental evidence does not discount the
proposed uncoupled switching mechanism, but such
experimental techniques are not yet sensitive enough
to detect the subpopulation should it exist.
For each mechanism, when each var gene in the
repertoire was allowed to switch on at rates greater
than 0–1% per generation, chronic patterns of
parasite recrudescence and fever could not be
predicted. This result contradicts the fast antigenic
switching rate of 2–4% per generation reported for
P. falciparum variants in vitro (Roberts et al. 1992).
However, this fast rate was based on 11 out of 21
clones switching after 30 generations (Roberts et al.
1992), and represents the sum of all variants that had
switched agglutinating characteristics relative to the
parent. It is not the rate at which a single variant
appears nor the rate at which a var gene is expressed.
Assuming that the antigenic variation was due solely
to changes in the PfEMP1 phenotype, then the rate
that a single variant may have switched on could be
as low as 0–16% (1fiexp†ln(20}21)}30·fl1–6‹10−$).
Our modelling predictions do not discount the fast
switching rates estimated both in vitro (Roberts et al.
1992) and in vivo (Brannan et al. 1994), but show
that an entire var gene repertoire consisting of fast
switching var genes would be exhausted within the
first few weeks of an infection. Such a repertoire is
therefore not compatible with chronic and stable
recrudescing parasitaemias. Molineaux et al. (2001)
produced similar results using a switch rate of 2%
per generation with a median of 45 variants being
expressed in the best runs of their model. However,
the problem of exhausting all of the var genes early
in the infection was resolved in their model by
allowing each variant to have a different multi-
plication rate.
A var gene repertoire in which a minority of genes
switch at a fast rate, creating the characteristic acute
phase of parasitaemia, and the remainder of var
genes switch at much slower rates, produces patterns
of recrudescing and chronic parasitaemia. This
rational is supported by experimental observations
which show variable antigen types of P. chabaudi
switching at differential rates (Brannan et al. 1994).
Indeed Roberts’ data (Roberts et al. 1992) also shows
that 2 out of the 11 clones switched to the same
variant type, implying that the switching probability
to this variant may have been higher than to any
other variant.
A repertoire of var genes, in which there is only a
small probability that some var genes will switch on
and be expressed due to slow switching rates, may
also explain why severe malaria is a relatively rare
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event considering the millions of people infected
with malaria annually. This supports the proposal
that severe malaria may be caused by only a small
proportion of the total var gene repertoire (Roberts
et al. 1993).
A close interaction between the thresholds gover-
ning NSI and VSI and the var gene switching rate
was revealed by the modelling. To sustain an
infection, Saul (1999) proposed that the switching
rate should be comparable with the rate at which
immune responses are generated. We extend this
proposal and suggest that the average switching rate
of each var gene repertoire should be inversely
related to the parasite load which induces a variant
specific immune response. Modelling predictions
also show that if the overall parasite growth rate is
reduced to approximately 4-fold per cycle by CSI,
then the severity of disease, illustrated as the fever
response, is markedly reduced. This has practical
implications for an anti-disease vaccine and shows
that a vaccine which boosts CSI would only have to
be 66% effective to have an impact on malaria
morbidity and the associated economic losses due to
malaria illness. Slow switching rates of PfEMP1
variants would enable such a vaccine to remain
effective.
The results of the modelling indicate that to
generate a chronic infection with parasite recrude-
scences, a complex and dynamic interaction between
VSI, CSI, NSI and the switching rate of var genes
exists. Var gene switching is a stochastic process
giving rise to phenotypic heterogeneity and we
propose a mechanism of uncoupled switching to
explain this heterogeneity and the patterns of chronic
parasitaemia. We have presented a robust and
biologically plausible model of a malaria infection.
This basic model can be extended to investigate
many other areas of a clinical infection. These
include the primary and secondary immune re-
sponses to conserved regions on multi-variant gene
families in addition to the variant regions modelled,
the change in the thresholds governing VSI, CSI
and NSI during the course of infection which would
likely influence disease severity, and the probability
of drug-resistant mutants surviving to transmission
with or without anti-malarial intervention.
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